Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Wiland

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Clinical Transplantation|October 15, 2013
A randomized, crossover pharmacokinetic study comparing generic tacrolimus vs. the reference formulation in subpopulations of kidney transplant patientsR D Bloom, J Trofe-Clark, A Wiland, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 5, 2012
A randomized pharmacokinetic study of generic tacrolimus versus reference tacrolimus in kidney transplant recipientsR R Alloway, B Sadaka, J Trofe-Clark, et al.
Transplantation Proceedings|December 29, 1998
Effectiveness of immunosuppressive treatment for recurrent or refractory pancreas allograft rejection: correlation with histologic gradeJ C Papadimitriou, A Wiland, C B Drachenberg, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 5, 2011
Cytomegalovirus incidence between everolimus versus mycophenolate in de novo renal transplants: pooled analysis of three clinical trialsD C Brennan, C Legendre, D Patel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 1998
Posttransplantation lymphoproliferative disorder associated with OKT3 and decreased antiviral prophylaxis in pancreas transplant recipientsS Keay, D Oldach, A Wiland, et al.
Transplantation Proceedings|May 30, 2001
Graft-versus-host disease-like features in mycophenolate mofetil-related colitisJ C Papadimitriou, C B Drachenberg, C O Beskow, et al.
Clinical Transplants|September 30, 1999
Kidney transplantation at the University of MarylandS T Bartlett, A C Farney, B E Jarrell, et al.
Transplantation|January 12, 1999
Histologic grading of acute allograft rejection in pancreas needle biopsy: correlation to serum enzymes, glycemia, and response to immunosuppressive treatmentJ C Papadimitriou, C B Drachenberg, A Wiland, et al.
Transplantation|August 25, 1999
Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlationC B Drachenberg, D K Klassen, M R Weir, et al.
Transplantation|January 12, 1999
The shrinking renal replacement therapy "break-even" pointE J Schweitzer, A Wiland, D Evans, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Clinical Transplantation|October 15, 2013
A randomized, crossover pharmacokinetic study comparing generic tacrolimus vs. the reference formulation in subpopulations of kidney transplant patientsR D Bloom, J Trofe-Clark, A Wiland, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 5, 2012
A randomized pharmacokinetic study of generic tacrolimus versus reference tacrolimus in kidney transplant recipientsR R Alloway, B Sadaka, J Trofe-Clark, et al.
Transplantation Proceedings|December 29, 1998
Effectiveness of immunosuppressive treatment for recurrent or refractory pancreas allograft rejection: correlation with histologic gradeJ C Papadimitriou, A Wiland, C B Drachenberg, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 5, 2011
Cytomegalovirus incidence between everolimus versus mycophenolate in de novo renal transplants: pooled analysis of three clinical trialsD C Brennan, C Legendre, D Patel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 1998
Posttransplantation lymphoproliferative disorder associated with OKT3 and decreased antiviral prophylaxis in pancreas transplant recipientsS Keay, D Oldach, A Wiland, et al.
Transplantation Proceedings|May 30, 2001
Graft-versus-host disease-like features in mycophenolate mofetil-related colitisJ C Papadimitriou, C B Drachenberg, C O Beskow, et al.
Clinical Transplants|September 30, 1999
Kidney transplantation at the University of MarylandS T Bartlett, A C Farney, B E Jarrell, et al.
Transplantation|January 12, 1999
Histologic grading of acute allograft rejection in pancreas needle biopsy: correlation to serum enzymes, glycemia, and response to immunosuppressive treatmentJ C Papadimitriou, C B Drachenberg, A Wiland, et al.
Transplantation|August 25, 1999
Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlationC B Drachenberg, D K Klassen, M R Weir, et al.
Transplantation|January 12, 1999
The shrinking renal replacement therapy "break-even" pointE J Schweitzer, A Wiland, D Evans, et al.
Pageof 2